Atıf Formatları
Nusinersen versus sham control in infantile-onset spinal muscular atrophy
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

R. S. Finkel Et Al. , "Nusinersen versus sham control in infantile-onset spinal muscular atrophy," New England Journal of Medicine , vol.377, no.18, pp.1723-1732, 2017

Finkel, R. S. Et Al. 2017. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. New England Journal of Medicine , vol.377, no.18 , 1723-1732.

Finkel, R. S., Mercuri, E., Darras, B. T., Connolly, A. M., Kuntz, N. L., Kirschner, J., ... Chiriboga, C. A.(2017). Nusinersen versus sham control in infantile-onset spinal muscular atrophy. New England Journal of Medicine , vol.377, no.18, 1723-1732.

Finkel, Richard Et Al. "Nusinersen versus sham control in infantile-onset spinal muscular atrophy," New England Journal of Medicine , vol.377, no.18, 1723-1732, 2017

Finkel, Richard S. Et Al. "Nusinersen versus sham control in infantile-onset spinal muscular atrophy." New England Journal of Medicine , vol.377, no.18, pp.1723-1732, 2017

Finkel, R. S. Et Al. (2017) . "Nusinersen versus sham control in infantile-onset spinal muscular atrophy." New England Journal of Medicine , vol.377, no.18, pp.1723-1732.

@article{article, author={Richard S. Finkel Et Al. }, title={Nusinersen versus sham control in infantile-onset spinal muscular atrophy}, journal={New England Journal of Medicine}, year=2017, pages={1723-1732} }